Summary

Global Travel Vaccines Market 2023-2027
The travel vaccines market is forecasted to grow by USD 3,715.53 mn during 2022-2027, accelerating at a CAGR of 8.64% during the forecast period. The report on the travel vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increase in global migration, the increase in awareness about vaccine-preventable diseases among travelers, and the mandate by countries on vaccinations prior to issuing visas.
Technavio's travel vaccines market is segmented as below:
By Disease Type
• Influenza
• Diphtheria
• Hepatitis
• Typhoid
• Others
By End-user
• Adult vaccines
• Pediatric vaccines
By Geographical Landscape
• North America
• Europe
• Asia
• Rest of World (ROW)
This study identifies the changes in the demographic profile of travelers globally as one of the prime reasons driving the travel vaccines market growth during the next few years. Also, increased incidence of travel-related diseases and initiatives by governments and other organizations to ensure travel safety will lead to sizable demand in the market.
The report on the travel vaccines market covers the following areas:
• Travel vaccines market sizing
• Travel vaccines market forecast
• Travel vaccines market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading travel vaccines market vendors that include Abbott Laboratories, Altimmune Inc., Bavarian Nordic AS, Bharat Biotech Ltd., CSL Ltd., Dynavax Technologies Corp., Emergent BioSolutions Inc., GlaxoSmithKline Plc, KM Biologics Co. Ltd., LG Chem Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., SK Chemicals Co. Ltd., Takeda Pharmaceutical Co. Ltd., Valneva SE, and AstraZeneca Plc. Also, the travel vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit - https://www.technavio.com/report/travel-vaccines-market-industry-analysis
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

ページTOPに戻る

Table of Contents

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Disease Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global travel vaccines market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on global travel vaccines market 2017 - 2021 ($ million)
o 4.2 Disease Type Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Disease Type Segment 2017 - 2021 ($ million)
o 4.3 End-user Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Disease Type
o 6.1 Market segments
o Exhibit 30: Chart on Disease Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Disease Type - Market share 2022-2027 (%)
o 6.2 Comparison by Disease Type
o Exhibit 32: Chart on Comparison by Disease Type
o Exhibit 33: Data Table on Comparison by Disease Type
o 6.3 Influenza - Market size and forecast 2022-2027
o Exhibit 34: Chart on Influenza - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Influenza - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Influenza - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Influenza - Year-over-year growth 2022-2027 (%)
o 6.4 Diphtheria - Market size and forecast 2022-2027
o Exhibit 38: Chart on Diphtheria - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Diphtheria - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Diphtheria - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Diphtheria - Year-over-year growth 2022-2027 (%)
o 6.5 Hepatitis - Market size and forecast 2022-2027
o Exhibit 42: Chart on Hepatitis - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Hepatitis - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Hepatitis - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Hepatitis - Year-over-year growth 2022-2027 (%)
o 6.6 Typhoid and others - Market size and forecast 2022-2027
o Exhibit 46: Chart on Typhoid and others - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Typhoid and others - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Typhoid and others - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Typhoid and others - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Disease Type
o Exhibit 50: Market opportunity by Disease Type ($ million)
o Exhibit 51: Data Table on Market opportunity by Disease Type ($ million)
• 7 Market Segmentation by End-user
o 7.1 Market segments
o Exhibit 52: Chart on End-user - Market share 2022-2027 (%)
o Exhibit 53: Data Table on End-user - Market share 2022-2027 (%)
o 7.2 Comparison by End-user
o Exhibit 54: Chart on Comparison by End-user
o Exhibit 55: Data Table on Comparison by End-user
o 7.3 Adult vaccines - Market size and forecast 2022-2027
o Exhibit 56: Chart on Adult vaccines - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Data Table on Adult vaccines - Market size and forecast 2022-2027 ($ million)
o Exhibit 58: Chart on Adult vaccines - Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Adult vaccines - Year-over-year growth 2022-2027 (%)
o 7.4 Pediatric vaccines - Market size and forecast 2022-2027
o Exhibit 60: Chart on Pediatric vaccines - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Data Table on Pediatric vaccines - Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Chart on Pediatric vaccines - Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Pediatric vaccines - Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by End-user
o Exhibit 64: Market opportunity by End-user ($ million)
o Exhibit 65: Data Table on Market opportunity by End-user ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America - Market size and forecast 2022-2027
o Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.4 Europe - Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 US - Market size and forecast 2022-2027
o Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.8 Germany - Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 Japan - Market size and forecast 2022-2027
o Exhibit 99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
o Exhibit 101: Chart on Japan - Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
o 9.11 China - Market size and forecast 2022-2027
o Exhibit 103: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 104: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 105: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 115: Abbott Laboratories - Overview
o Exhibit 116: Abbott Laboratories - Business segments
o Exhibit 117: Abbott Laboratories - Key news
o Exhibit 118: Abbott Laboratories - Key offerings
o Exhibit 119: Abbott Laboratories - Segment focus
o 12.4 AstraZeneca Plc
o Exhibit 120: AstraZeneca Plc - Overview
o Exhibit 121: AstraZeneca Plc - Product / Service
o Exhibit 122: AstraZeneca Plc - Key news
o Exhibit 123: AstraZeneca Plc - Key offerings
o 12.5 Bharat Biotech Ltd.
o Exhibit 124: Bharat Biotech Ltd. - Overview
o Exhibit 125: Bharat Biotech Ltd. - Product / Service
o Exhibit 126: Bharat Biotech Ltd. - Key news
o Exhibit 127: Bharat Biotech Ltd. - Key offerings
o 12.6 CSL Ltd.
o Exhibit 128: CSL Ltd. - Overview
o Exhibit 129: CSL Ltd. - Business segments
o Exhibit 130: CSL Ltd. - Key news
o Exhibit 131: CSL Ltd. - Key offerings
o Exhibit 132: CSL Ltd. - Segment focus
o 12.7 Dynavax Technologies Corp.
o Exhibit 133: Dynavax Technologies Corp. - Overview
o Exhibit 134: Dynavax Technologies Corp. - Product / Service
o Exhibit 135: Dynavax Technologies Corp. - Key offerings
o 12.8 GlaxoSmithKline Plc
o Exhibit 136: GlaxoSmithKline Plc - Overview
o Exhibit 137: GlaxoSmithKline Plc - Business segments
o Exhibit 138: GlaxoSmithKline Plc - Key news
o Exhibit 139: GlaxoSmithKline Plc - Key offerings
o Exhibit 140: GlaxoSmithKline Plc - Segment focus
o 12.9 KM Biologics Co. Ltd.
o Exhibit 141: KM Biologics Co. Ltd. - Overview
o Exhibit 142: KM Biologics Co. Ltd. - Product / Service
o Exhibit 143: KM Biologics Co. Ltd. - Key offerings
o 12.10 LG Chem Ltd.
o Exhibit 144: LG Chem Ltd. - Overview
o Exhibit 145: LG Chem Ltd. - Business segments
o Exhibit 146: LG Chem Ltd. - Key news
o Exhibit 147: LG Chem Ltd. - Key offerings
o Exhibit 148: LG Chem Ltd. - Segment focus
o 12.11 Merck and Co. Inc.
o Exhibit 149: Merck and Co. Inc. - Overview
o Exhibit 150: Merck and Co. Inc. - Business segments
o Exhibit 151: Merck and Co. Inc. - Key news
o Exhibit 152: Merck and Co. Inc. - Key offerings
o Exhibit 153: Merck and Co. Inc. - Segment focus
o 12.12 Novartis AG
o Exhibit 154: Novartis AG - Overview
o Exhibit 155: Novartis AG - Business segments
o Exhibit 156: Novartis AG - Key offerings
o Exhibit 157: Novartis AG - Segment focus
o 12.13 Pfizer Inc.
o Exhibit 158: Pfizer Inc. - Overview
o Exhibit 159: Pfizer Inc. - Product / Service
o Exhibit 160: Pfizer Inc. - Key news
o Exhibit 161: Pfizer Inc. - Key offerings
o 12.14 Sanofi SA
o Exhibit 162: Sanofi SA - Overview
o Exhibit 163: Sanofi SA - Business segments
o Exhibit 164: Sanofi SA - Key news
o Exhibit 165: Sanofi SA - Key offerings
o Exhibit 166: Sanofi SA - Segment focus
o 12.15 Serum Institute of India Pvt. Ltd.
o Exhibit 167: Serum Institute of India Pvt. Ltd. - Overview
o Exhibit 168: Serum Institute of India Pvt. Ltd. - Product / Service
o Exhibit 169: Serum Institute of India Pvt. Ltd. - Key offerings
o 12.16 Takeda Pharmaceutical Co. Ltd.
o Exhibit 170: Takeda Pharmaceutical Co. Ltd. - Overview
o Exhibit 171: Takeda Pharmaceutical Co. Ltd. - Product / Service
o Exhibit 172: Takeda Pharmaceutical Co. Ltd. - Key news
o Exhibit 173: Takeda Pharmaceutical Co. Ltd. - Key offerings
o 12.17 Valneva SE
o Exhibit 174: Valneva SE - Overview
o Exhibit 175: Valneva SE - Business segments
o Exhibit 176: Valneva SE - Key offerings
o Exhibit 177: Valneva SE - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 178: Inclusions checklist
o Exhibit 179: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 180: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 181: Research methodology
o Exhibit 182: Validation techniques employed for market sizing
o Exhibit 183: Information sources
o 13.5 List of abbreviations
o Exhibit 184: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits6: Executive Summary - Chart on Market Segmentation by End-user
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global travel vaccines market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Disease Type Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Disease Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Disease Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Disease Type
Exhibits33: Data Table on Comparison by Disease Type
Exhibits34: Chart on Influenza - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Influenza - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Influenza - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Influenza - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Diphtheria - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Diphtheria - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Diphtheria - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Diphtheria - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Hepatitis - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Hepatitis - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Hepatitis - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Hepatitis - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Typhoid and others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Typhoid and others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Typhoid and others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Typhoid and others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Disease Type ($ million)
Exhibits51: Data Table on Market opportunity by Disease Type ($ million)
Exhibits52: Chart on End-user - Market share 2022-2027 (%)
Exhibits53: Data Table on End-user - Market share 2022-2027 (%)
Exhibits54: Chart on Comparison by End-user
Exhibits55: Data Table on Comparison by End-user
Exhibits56: Chart on Adult vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits57: Data Table on Adult vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits58: Chart on Adult vaccines - Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Adult vaccines - Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Pediatric vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits61: Data Table on Pediatric vaccines - Market size and forecast 2022-2027 ($ million)
Exhibits62: Chart on Pediatric vaccines - Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Pediatric vaccines - Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by End-user ($ million)
Exhibits65: Data Table on Market opportunity by End-user ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits100: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits101: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits104: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits105: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Abbott Laboratories - Overview
Exhibits116: Abbott Laboratories - Business segments
Exhibits117: Abbott Laboratories - Key news
Exhibits118: Abbott Laboratories - Key offerings
Exhibits119: Abbott Laboratories - Segment focus
Exhibits120: AstraZeneca Plc - Overview
Exhibits121: AstraZeneca Plc - Product / Service
Exhibits122: AstraZeneca Plc - Key news
Exhibits123: AstraZeneca Plc - Key offerings
Exhibits124: Bharat Biotech Ltd. - Overview
Exhibits125: Bharat Biotech Ltd. - Product / Service
Exhibits126: Bharat Biotech Ltd. - Key news
Exhibits127: Bharat Biotech Ltd. - Key offerings
Exhibits128: CSL Ltd. - Overview
Exhibits129: CSL Ltd. - Business segments
Exhibits130: CSL Ltd. - Key news
Exhibits131: CSL Ltd. - Key offerings
Exhibits132: CSL Ltd. - Segment focus
Exhibits133: Dynavax Technologies Corp. - Overview
Exhibits134: Dynavax Technologies Corp. - Product / Service
Exhibits135: Dynavax Technologies Corp. - Key offerings
Exhibits136: GlaxoSmithKline Plc - Overview
Exhibits137: GlaxoSmithKline Plc - Business segments
Exhibits138: GlaxoSmithKline Plc - Key news
Exhibits139: GlaxoSmithKline Plc - Key offerings
Exhibits140: GlaxoSmithKline Plc - Segment focus
Exhibits141: KM Biologics Co. Ltd. - Overview
Exhibits142: KM Biologics Co. Ltd. - Product / Service
Exhibits143: KM Biologics Co. Ltd. - Key offerings
Exhibits144: LG Chem Ltd. - Overview
Exhibits145: LG Chem Ltd. - Business segments
Exhibits146: LG Chem Ltd. - Key news
Exhibits147: LG Chem Ltd. - Key offerings
Exhibits148: LG Chem Ltd. - Segment focus
Exhibits149: Merck and Co. Inc. - Overview
Exhibits150: Merck and Co. Inc. - Business segments
Exhibits151: Merck and Co. Inc. - Key news
Exhibits152: Merck and Co. Inc. - Key offerings
Exhibits153: Merck and Co. Inc. - Segment focus
Exhibits154: Novartis AG - Overview
Exhibits155: Novartis AG - Business segments
Exhibits156: Novartis AG - Key offerings
Exhibits157: Novartis AG - Segment focus
Exhibits158: Pfizer Inc. - Overview
Exhibits159: Pfizer Inc. - Product / Service
Exhibits160: Pfizer Inc. - Key news
Exhibits161: Pfizer Inc. - Key offerings
Exhibits162: Sanofi SA - Overview
Exhibits163: Sanofi SA - Business segments
Exhibits164: Sanofi SA - Key news
Exhibits165: Sanofi SA - Key offerings
Exhibits166: Sanofi SA - Segment focus
Exhibits167: Serum Institute of India Pvt. Ltd. - Overview
Exhibits168: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibits169: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibits170: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits171: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits172: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits173: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits174: Valneva SE - Overview
Exhibits175: Valneva SE - Business segments
Exhibits176: Valneva SE - Key offerings
Exhibits177: Valneva SE - Segment focus
Exhibits178: Inclusions checklist
Exhibits179: Exclusions checklist
Exhibits180: Currency conversion rates for US$
Exhibits181: Research methodology
Exhibits182: Validation techniques employed for market sizing
Exhibits183: Information sources
Exhibits184: List of abbreviations